文献速递免疫规划传染病防控与疫情报告

日本儿童结核病与卡介苗接种

Pediatric tuberculosis and BCG vaccine in Japan.
PubMed 文献 · Vaccine · 2025-08-08

日本结核病曾为重大公共卫生问题,二战后通过强制报告、大规模卡介苗接种和抗结核药物使发病率与死亡率显著下降。1949年开始大规模接种,1974年实施儿童普遍接种,采用皮内多针「印章法」以减少皮肤溃疡并发症。当前使用1981年开发的Tokyo-172-1株,儿童结核病已罕见,每年新病例少于100例,但境外出生者病例比例上升,普遍接种政策正在审视。

要点

  • 日本1949年开始大规模卡介苗接种,1974年实施儿童普遍接种。
  • 采用皮内多针「印章法」接种以减轻皮肤溃疡并发症。
  • 当前使用1981年开发的Tokyo-172-1株,经WHO-UNICEF计划全球分发。

核心结论

  • 日本儿童结核病已罕见,每年新病例少于100例,但境外出生者病例比例上升,普遍卡介苗接种的延续正在审视。

研究设计与样本

  • 本文为综述,梳理日本结核病控制历史、卡介苗接种政策与儿童结核病现状。

主要发现

  • 二战后强制病例报告、大规模卡介苗接种和链霉素等抗结核药物使结核发病率与死亡率显著下降。
  • 1949年开始大规模卡介苗接种,1974年实施儿童普遍接种。
  • 采用皮内多针「印章法」接种以减少皮肤溃疡并发症。
  • 当前使用1981年开发的Tokyo-172-1株,全国使用并通过WHO-UNICEF计划全球分发。
  • 儿童结核病每年新病例少于100例,多数通过成人接触者调查发现,其余基于临床症状或筛查诊断。

临床怎么用

  • 作者认为,随着日本转为低结核负担,可考虑对高风险婴儿选择性接种并加强成人筛查,作为更具针对性的方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tuberculosis (TB) was a significant public health concern in Japan for over a century. While archaeological evidence suggests its presence as early as 1800 years ago, TB spread rapidly during Japan's modernization in the late 19th century. Initial control measures focused on patient isolation and the establishment of sanatoriums, later supported by the Tuberculosis Prevention Law. After World War II, public health interventions-such as mandatory case reporting, mass BCG vaccination, and the introduction of antimycobacterial agents like streptomycin-contributed to a marked decline in TB incidence and mortality. Treatment outcomes further improved with the development of multidrug chemotherapy. Mass BCG vaccination began in 1949, with universal childhood vaccination implemented in 1974. Japan employs a distinctive intradermal "stamp" method with multiple needles of BCG administration for less complication of a skin ulcer. The current strain, BCG Tokyo-172-1, developed in 1981, is used nationally and distributed globally through WHO-UNICEF programs. Pediatric TB has become rare, with fewer than 100 new cases annually. Most are identified through adults contact investigations; others are diagnosed based on clinical symptoms or screening. In recent years, the proportion of TB cases-including pediatric cases-among individuals born outside Japan, particularly from high-burden countries, has increased. As Japan transitions to a low TB burden setting, the continuation of universal BCG vaccination is under review. Selective vaccination of high-risk infants and enhanced screening among adults may offer more targeted and effective approaches.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Horikoshi Y, Toizumi M. Pediatric tuberculosis and BCG vaccine in Japan. Vaccine. 2025. PMID: 40780094. doi:10.1016/j.vaccine.2025.127564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。